Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer

Summary

RATIONALE: Sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Giving sunitinib before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. PURPOSE: This clinical trial is studying the side effects of giving sunitinib before surgery and to see how well it works in treating patients with localized or metastatic kidney cancer.

Timeline

Start

2007-08

Primary completion

2009-07

Completion

2010-04

Drugs

Indications